Parallel analysis of serum epcam and mmp7 to discriminate sepsis, necrotizing enterocolitis and normal control patients
OwnerBruce Xuefeng Ling, Karl G. Sylvester +3inventors
InventorsBruce Xuefeng Ling, Karl G. Sylvester, Changlin Fu, Shan Xiang Wang, Dokyoon Kim
Life of this patent
Estimating the term…
Abstract
Methods and compositions are provided for making a necrotizing enterocolitis (NEC) or sepsis assessment of an individual. Aspects of the methods include detecting a biomarker or panel of biomarkers selected from MMP7, EpCAM, and CRP. In addition, reagents, devices, systems and kits thereof that find use in practicing the subject methods are provided.
Claims19
A method of making an NEC/sepsis assessment of a subject, the method comprising:
- detecting the level of MMP7 in a blood sample from a subject to arrive at a biomarker signature representative of the level of MMP7 in the sample, and
- making the NEC/sepsis assessment of a subject based upon the biomarker signature.
(canceled)
A device for making an NEC or sepsis assessment, the device comprising a magnetic nanoparticle sensor configured to detect one or more proteins selected from MMP7, EpCAM and CRP in a fluid sample from a subject.
A kit comprising:
- one or more biotinylated antibodies selected from a biotinylated antibody specific for MMP7, a biotinylated antibody specific for EpCAM, and a biotinylated antibody specific for CRP;
- and
- streptavidin-labeled magnetic nanoparticles.
Dependencies are inferred from the claim text.